Who are Piperacillin And Tazobactam's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Pipracil.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/piperacillin-and-tazobactam.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Piperacillin And Tazobactam — Competitive Intelligence Brief

Piperacillin And Tazobactam (Piperacillin Sodium) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Penicillin-class antibacterial with beta-lactamase inhibitor. Area: Infectious Disease.

marketed Penicillin-class antibacterial with beta-lactamase inhibitor Bacterial cell wall; beta-lactamase enzyme Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Piperacillin And Tazobactam (Piperacillin Sodium) — Pfizer. Piperacillin and tazobactam is an antibacterial drug combining a penicillin with a beta-lactamase inhibitor.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Piperacillin And Tazobactam TARGET	Piperacillin Sodium	Pfizer	marketed	Penicillin-class antibacterial with beta-lactamase inhibitor	Bacterial cell wall; beta-lactamase enzyme	1981-01-01
Pipracil	Piperacillin Sodium	Pfizer Inc.	marketed	Penicillin-class antibacterial with beta-lactamase inhibitor	Beta-lactamase producing bacteria	1981-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Penicillin-class antibacterial with beta-lactamase inhibitor class)

Pfizer · 1 drug in this class
Pfizer Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Piperacillin And Tazobactam — Competitive Intelligence Brief. https://druglandscape.com/ci/piperacillin-and-tazobactam. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab